epigallocatechin gallate has been researched along with Bright Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; Mohan, C; Peng, A; Vaziri, ND; Xu, Y; Ye, T; Zhen, J; Zhou, JK; Zhou, XJ | 1 |
1 other study(ies) available for epigallocatechin gallate and Bright Disease
| Article | Year |
|---|---|
Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.
Topics: Animals; Antioxidants; Catechin; Glomerulonephritis; Kidney; Male; Mice; Mice, 129 Strain; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; Oxidative Stress; PPAR gamma; Signal Transduction; Sirtuin 1; Tea | 2015 |